continua IL black FRIDAY al CUBO |15% su tutto con il coupon 15alcubo | SCOPRI di più

Customer care
  • DAKTARIN DERMATOLOGICO Cream 30g -35%

DAKTARIN DERMATOLOGICO Cream 30g

10.68€ 16.50€
  • Purchase 3 items for 10.47€ each
  • Purchase 4 items for 10.25€ each
  • Purchase 5 items for 10.04€ each

DAKTARIN DERMATOLOGICO Cream - Medical Device

DAKTARIN DERMATOLOGICO contains miconazole nitrate, which belongs to a group of medicines called 'antifungals' used to treat fungal infections.

DAKTARIN DERMATOLOGICO is a dermatological medicine indicated for the treatment of skin or nail infections caused by fungi (dermatophytes) or yeast (Candida) possibly complicated by bacterial infections.

Talk to your doctor if you don't feel better or if you feel worse.

Indications

Daktarin dermatological cream is indicated in infections of the skin or nails caused by dermatophytes or Candida possibly complicated by superinfections by Gram-positive bacteria.

Composition and active ingredients

100 g of DAKTARIN CREAM contain

  • Active ingredients: miconazole nitrate 2 g. 20 mg / g
  • Excipients: polyethylene glycol palmito stearate, macrogol, glycerol oleate, liquid paraffin, butylhydroxyanisole, benzoic acid, purified water.

Contraindications and side effects

Daktarin antifungal cream is contraindicated in case of:

  • hypersensitivity to the active substance, to other imidazole derivatives or to any of the listed excipients;
  • infants and children (up to 12 years).

Side effects considered related to the drug are:

  • burning sensation of the skin,
  • inflammation of the skin,
  • skin hypopigmentation,
  • irritation at the application site with burning and itching,
  • anaphylactic reactions (Very rare),
  • angioedema (Very rare),
  • hives (Very rare),
  • contact dermatitis (Very rare),
  • rash (Very rare),
  • erythema (Very rare).

Method of administration, dosages and posology

In case of skin infections, treatment should be continued daily and continuously at least up to a week after the symptoms disappear, and can last from 2 to 6 weeks, depending on the type and extent of the infection.

  1. Wash the affected area and dry well.
  2. Treat not only the infected part, but also the area around it.
  3. Wash your hands thoroughly after each application to avoid transferring germs to other parts of the body or to other people.
  4. For a faster effect it is recommended to associate DAKTARIN CREAM with DAKTARIN POWDER in this case it is sufficient to use both the powder and the cream once a day.

In foot infections it is recommended to sprinkle the feet with powder daily during and after treatment with the cream, especially the spaces between the toes, as well as socks and shoes. How to use and dosage: apply 1 centimeter of cream on the lesion (or more depending on the extent of the lesion) 2 times a day, then spread with your fingers until completely absorbed.

storage

Store at a temperature not exceeding 25 °.

Warnings

  • If sensitization or irritation occurs, discontinue treatment and institute appropriate therapy.
  • Avoid contact with eyes.
  • Wash your hands carefully after each application, unless the treatment affects the hands themselves.
  • It is advisable to apply the following hygienic measures to avoid the sources of infections or reinfections: keep towels and underwear for personal use in order to avoid the infection of other people; regularly change clothing that comes into contact with the infected area to avoid re-infection. It does not stain the skin or clothing.
  • Severe hypersensitivity reactions, including anaphylaxis and angioedema, have been reported during treatment with the drug and other topical miconazole formulations. If a reaction due to hypersensitivity or irritation occurs, the treatment should be discontinued.
  • The product must not come into contact with the mucous membrane of the eyes.
  • Important information about some of the ingredients: the cream contains benzoic acid which may be mildly irritating to the skin, eyes and mucous membranes.

Interactions

  • Systemically administered miconazole is known to inhibit CYP3A4 / 2C9. Since, following local application, the presence of the drug in the blood is limited, interactions deemed clinically relevant are very rare. However, in patients treated with oral anticoagulants, such as warfarin, caution and anticoagulant action should be monitored.
  • The efficacy and undesirable effects of other drugs (e.g. oral hypoglycemic agents and phenytoin), when administered concomitantly with miconazole, may be increased and special caution is therefore required.

Pregnancy and breastfeeding

The drug, applied topically, is minimally absorbed into the systemic circulation (bioavailability <1%). However, while there is no evidence of embryotoxicity or teratogenicity in animals, the potential risks of prescribing the drug during pregnancy must be weighed against the potential therapeutic benefits. Miconazole, applied topically, is minimally absorbed into the systemic circulation and it is not known whether miconazole is excreted in human milk. Caution is advised in the use of topical products containing miconazole during breastfeeding.

Format

30 g tube.

.